miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|20|10|1974-1983

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.20, Iss.10, 2016-10, pp. : 1974-1983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of deubiquitinating enzyme USP28 promoted non‐small cell lung cancer growth

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 4, 2015-04 ,pp. : 799-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 4, 2015-04 ,pp. : 760-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐15b‐5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1855-1863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic regulation of miR‐129‐2 and its effects on the proliferation and invasion in lung cancer cells

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 9, 2015-09 ,pp. : 2172-2180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1923-1930

John Wiley & Sons Inc

Access to resources Recommend Favorite